New Distributor of Mobidiag Multiplex Gastrointestinal Tests to CEE Countries
Under a new agreement with Mobidiag Ltd., Biomedica Medizinprodukte will become the exclusive distributor of Amplidiag®, in vitro diagnostics for gastrointestinal infections, in Central and Eastern Europe (Austria, Bosnia & Herzegovina, Bulgaria, Croatia, Czech Republic, Hungary, Macedonia, Poland, Romania, Serbia, Slovakia, Slovenia). Suitable for mid-sized to large laboratories, the real-time PCR based Amplidiag® multiplex tests allow simultaneous screening for the most relevant gastrointestinal pathogens.
“Since Mobidiag’s inception, we have been focusing our activity towards Nordic region and France mainly. Three months ago, we have started developing our distribution network by extending our European coverage to Spain and Benelux. We are very pleased today to expand Amplidiag accessibility to Central and Eastern Europe with the support of our partner, Biomedica Medizinprodukte” said Tuomas Tenkanen, CEO at Mobidiag.
“Rapid and reliable detection of gastrointestinal infections is crucial for preventing transmission of contagious pathogens. With Amplidiag products, we will ensure the distribution of innovative, quality products that will significantly impact infection control” said Dr. Michaela Weblacher, Executive Vice President at Biomedica.
The distribution agreement is effective immediately and covers all Amplidiag® products (Amplidiag® H. pylori+ClariR, Amplidiag® Stool Parasites, Amplidiag® CarbaR+VRE, Amplidiag® C. difficile+027, Amplidiag® Bacterial GE, Amplidiag® Easy and upcoming Amplidiag® Viral GE).
For more information visit - www.mobidiag.com
Tags: Clostridium difficile, Cryptosporidium/Giardia, Enteroviruses, Helicobacter pylori, Gastroenteritis
Date Published: September 5, 2016
Source article link: Mobidiag Oy (HQ) » company contact details
FDA Clearance for ARIES C. difficile Assay Detecting both Toxin A and B
Immunoassay for Giardia, Cryptosporidium and E. histolytica in Fecal Specimens
CE-IVD Marking for ELITechGroup Multiplex Viral Meningitis Panel
FDA Clearance for Solana® C. difficile Molecular Assay
Study Shows FecalSwab™ Improved LOD for Enteric Pathogens